- cafead   Jan 14, 2021 at 12:12: AM
via Preclinical biotech company Sana Biotechnology has filed with the U.S. Securities and Exchange Commission to raise up to $150 million in an initial public offering (IPO) to help support the company’s cell-based therapy discovery and development operations.
article source
article source